HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke.

Abstract
We investigated 32 patients with completed ischemic stroke less than or equal to 6 hours after the onset of symptoms by means of computed tomography, cerebral angiography, and technetium-99m-labeled hexamethylpropyleneamine oxime single-photon emission computed tomography to study cerebral blood flow. Follow-up computed tomography and cerebral blood flow studies were performed 1 week and 1 month after admission. Poor outcome at 1 month was evident in 18 (78%) of the 23 patients with severe neurologic deficit on admission and in 11 (92%) of the 12 patients with severe hypoperfusion in the affected hemisphere on admission. All 10 patients with severe impairment of both neurologic status and cerebral blood flow had a poor outcome at 1 month. We detected severe hypoperfusion in patients with large lesions on computed tomograms or cerebral artery occlusions on angiograms. Cerebral blood flow had increased at the 1-week follow-up despite different clinical outcomes. Our data provide evidence that early evaluation of cerebral blood flow with single-photon emission computed tomography is useful to detect subgroups of patients with different clinical outcomes during the acute phase of ischemic stroke.
AuthorsF Giubilei, G L Lenzi, V Di Piero, C Pozzilli, P Pantano, S Bastianello, C Argentino, C Fieschi
JournalStroke (Stroke) Vol. 21 Issue 6 Pg. 895-900 (Jun 1990) ISSN: 0039-2499 [Print] United States
PMID2349593 (Publication Type: Journal Article)
Topics
  • Brain Ischemia (complications, diagnostic imaging, pathology, physiopathology)
  • Cerebrovascular Circulation
  • Female
  • Humans
  • Male
  • Neurologic Examination
  • Predictive Value of Tests
  • Prognosis
  • Time Factors
  • Tomography, Emission-Computed, Single-Photon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: